Curriculum Vitae
Total Page:16
File Type:pdf, Size:1020Kb
CURRICULUM VITAE Tony Y. Hu Ph.D. Tel: 480-965-1880 Email: [email protected] DEMOGRAPHIC AND PERSONAL INFORMATION Current Appointments Associate Professor November 2016 - Present School of Biological and Health Systems Engineering Virginia G. Piper Biodesign Center for Personalized Diagnostics The Biodesign Institute Arizona State University Associate Professor January 2016 – October 2016 Assistant Professor January 2011 – December 2015 Department of Nanomedicine Director, Proteomic Nanoengineering Core Houston Methodist Research Institute, Houston, TX, 77030 USA Department of Cell and Developmental Biology Weill Cornell Medical College, New York City, NJ, 10065 USA Education and Training (in chronological order): Year Degree/Certificate Institution Discipline • Undergraduate 1999 Bachelor, Lanzhou University Organic Chemistry • Graduate 2004 Master, Univ. of Texas at Austin Chemistry and Biochemistry • Doctoral 2009 Ph.D., Univ. of Texas at Austin Biomedical Engineering • Postdoctoral 2009-2011 Univ. of Texas Health Science Center at Houston Nanomedicine Professional Experience Dates Positions Institutions 09.1999 – 11. 2001 Graduate Research Assistant Tsinghua University, China 12/2011 – Present Editorial Member Journal of Proteomic Science and Computational Biology 10/2013 – 05. 2014 Guest Editor Journal of Theranostics 03/2016 – Present Editorial Member Journal of Theranostics 07/2015 - Present Associate Editor Fundamental Biomedical Technologies RESEARCH ACTIVITIES Recent Publications (2010 ~ 2015): a. Manuscripts under review/revision 1. Fan, J., Wei, Q., Koay, E. J., Bernard, P.W., Kai, M., Borsoi, C., Bernard, D.W., Zhang, N., Katz, M.H., Yokoi, K., Zhao, Z., Hu Y. * Exosome-enriched EphA2 confers chemoresistance and predicts response to cytotoxic therapy in pancreatic cancer. Molecular Oncology. 2017, under review. 2. Xu, T., Fan, J., Huo, J., Levy, L.B., Bone, C. R., Gomez, D., Liao, Z., Hu, Y. *Predictive value of serum hepcidin for disease outcome in non-small cell lung cancer patients received definitive radio(chemo)therapy. Cancer Letter 2017, under review. b. Published Articles 3. Sun, D., Hu, Y. A low cost mobile phone-based dark-field microscope for nanoparticle-based quantitative studies. Biosensors and Bioelectronics 2017, 15;99:513-518. 4. Rodrigues, M., Fan, J., Lyon, C. J., Hu, Y. Exosomes in infectious diseases: Pathogenesis, Diagnostics, and Therapeutics. Theranostics 2018, in press (Cover Story). 5. Zhang, W., Shu, Q., Zhao, Z., Fan, J., Lyon, C. J., Zelazny, A., Hu, Y. Antigen 85B peptidomic analysis allows species-specific mycobacterial identification. Clinical Proteomics 2018, 15:1. 6. Liu, C., Lyon, C. J., Deng, Z., Walters, E., Li, Y., Zhang, L., Hesseling, A., Hu, Y. Clinical evaluation of a blood assay to diagnose paucibacillary tuberculosis via bacterial antigens. Clinical Chemistry 2018, accepted (Cover Story). 7. Fan, J., Zhang, H., Nguyen, D., Lyon, C. J., Mitchell, C. D., Zhao, Z., Graviss, E. A., Hu, Y. Rapid diagnosis of new and recurrent tuberculosis by quantification of circulating antigen in HIV-infected adults in the Greater Houston Metropolitan area: a retrospective cohort study. BMC Medicine 2017, 15:188. 8. Wu, B., Ouyang, Z., Lyon, C. J., Zhang, W., Clift, T., Bone, C., Zhao, Z., Kimata, J., Hu, Y. Plasma C4b peptide levels and HLA-B*57 genotype are associated with spontaneous HIV suppression in HIV-1- infected patients. ACS Infect. Dis. 2017, 3 (12): 880–885. 9. Liu, C., Zhao, Z., Fan, J., Lyon, C. J., Wu, H., Nedelokv, D., Zelazny, A.M., Olivier, K.N., Cazares, L.H., Holland, S.H., Graviss, E. A., Hu, Y. Quantification of Circulating M. tuberculosis Antigens for Rapid Diagnosis and Real-time Treatment Monitoring. Proc. Natl. Acad. Sci. U S A. 2017, 114(15):3969-3974. (Highlighted by New England Journal of Medicine) 10. Liang K., Liu, F., Fan, J., Sun, D., Bernard, D. W., Li, Y., Yokoi, K., Katz, M. H., Koay, E. J., Zhao, Z., Hu, Y. Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples for Diagnosis and Treatment Monitoring. Nature Biomedical Engineering. 2017, 1:0021. (Highlighted by Nature Review Gastroenterology & Hepatology) 11. Liang, K., Wu, H., Hu, Y., Li, Y. Mesoporous silica chip: enabled peptide profiling as an effective platform for controlling bio-sample quality and optimizing handling procedure. Clinical Proteomics. 2017, 13(1), 34. 12. Li, H., Yang, S., Yu, G., Shen, L., Fan, J., Xu, L., Zhang, H., Zhao, N., Zeng, Z. Hu, Y., Wen, J., Zu, Y. Aptamer internalization via endocytosis inducing S-phase arrest and priming Maver-1 lymphoma cells for cytarabine chemotherapy. Theranostics. 2017, 7(5): 1204-1213. 13. Sun, D., Fan, J., Liu, C., Liu, Y., Bu, Y., Lyon, C. J., Hu, Y. A noise reduction method for quantifying nanoparticle light scattering in low magnification dark-field microscope far-field images. Anal. Chem. 2016, 88(24): 12001-12005. 14. Li, Y., Hu, Y. Decoding the Blood Peptidome as a New Biomarker Resource for Cancer Detection. MOJ Proteomics Bioinform. 2016, 3(5):00099. 15. Wang, J., Dong, A., Liu, G., Anderson, G.J., Hu, Y., Shi, J., Hu, Y., Nie G. Correlation of serum hepcidin levels with disease progression in hepatitis B virus-related disease assessed by nanopore film based assay. Sci. Rep. 2016, 6:34252. 16. Zhu, L., Olsen, R., Horstmann, N., Shelburne, S., Fan, J., Hu, Y., Musser, J. Intergenic VNTR Polymorphism Upstream of rocA Alters Toxin Production and Enhances Virulence in Streptococcus pyogenes. Infect. Immun. 2016, 84(7): 2086-93. 17. Qian, X., Nguyen, D.T.M., Li, Y., Lyu, J., Graviss, E.A., Hu, Y. * Predictive value of serum bradykinin and desArg9-bradykinin levels for chemotherapeutic responses in active tuberculosis patients: A retrospective case series. Tuberculosis. 2016, pii: S1472-9792 (16): 30407-3. 18. Hu, Y. * Can Sugarcoated Fingerprints be used to Identify Lurking Viruses? Proteomics. 2016, 16: 1947- 1948. 19. Mi, Y., Mu, C., Wolfram, J., Deng, Z., Hu, Y., Liu, X., Blanco, E., Shen, H., Ferrari, M. A Micro/Nano Composite for Combination Treatment of Melanoma Lung Metastasis. Adv Healthc Mater. 2016, Apr; 5(8): 936-46. 20. Ma, X., Chong, L., Tian, R., Shi, R., Hu, Y., Ouyang, Z., Xia, Y. Identification and quantitation of lipid C=C location isomers: a shotgun lipidomics approach coupled with photochemical reaction. Proc. Natl. Acad. Sci. U S A. 2016 Mar 8; 113 (10): 2573-8. 21. Fan, J., Tea, M., Ma, L., Meng, Q., Hu, Y. *, Singer, C., Ferrari, M. * Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer. J Proteomics Res 2016, 15(5): 1534-45. 22. Ren, Y., Wang, R., Gao, L., Li, K., Zhou, X., Guo, H., Liu, C., Han, D., Tian, J., Ye, Q., Hu, Y., Sun, D., Yuan, X., Zhang, N. * Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy, Journal of Controlled Release. 2016, 228(28): 74-86. 23. Du, Y., Hu, Y., Xia, Y., Ouyang, Z. Power Normalization for Mass Spectrometry Data Analysis and Analytical Method Assessment. Anal. Chem., 2016, 88 (6), pp 3156–3163. 24. Huang, H., Tao, L., Liu, F., Ji, L., Hu, Y., Cheng, M., Chen, P., Akinwande, D. Chemical-Sensitive Graphene Modulator with Memory Effect for Internet-of-Things Applications. Nature: Microsystems & Nanoengineering 2016, 2:16018. 25. Khaled, S. Z., Cevenini, A., Yazdi, I. K., Parodi, A., Evangelopoulos, M., Corbo, C., Scaria, S., Hu, Y., Haddix, S. G., Corradetti, B. Salvatore, F., Tasciotti, E. One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA. Biomaterials 2016, 87:57-68. 26. Deng, Z., Li, Y., Fan, J., Wang G., Li, Y., Zhang Y., Cai G., Shen, H., Hu, Y. Circulating Peptidome to Indicate the Tumor-resident Proteolysis. Scientific Reports. 2015, 5:9327. 27. Wang, J., Liu, G., Xu, Z., Dai, J., Song, P., Shi, J., Hu, Y., Hu, Z., Nie, G., Chan, Y., Zhao, Y. Hepcidin levels in hyperprolactinemic women monitored by nanopore thin film based assay: Correlation with pregnancy-associated hormone prolactin. Nanomedicine: NBM. 2015, 11(4): 871-878. 28. Zhang P., Wei Y., Wang L., Debeb B. G., Yuan Y., Zhang J., Yuan J., Wang M., Chen D., Sun Y., Woodward W. A., Liu Y., Dean D. C., Liang H., Hu Y., Ang K. K., Hung M. C., Chen J., Ma L. ATM- mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1, Nature Cell Bio. 2014, 16(9): 864-875. 29. Zhang P., Wang L., Rodriguez-Aguayo C., Yuan Y., Debeb B. G., Chen D., Sun Y., You M. J., Liu Y., Dean D. C., Woodward W. A., Liang H., Yang X., Lopez-Berestein G., Sood A. K., Hu Y., Ang K. K., Chen J., Ma L. miR-205 acts as a tumor radiosensitizer by targeting ZEB1 and Ubc13, Nature Communications. 2014, 5:5671. 30. Li Y., Li Y., Chen T., Kuklina A. S., Bernard P., Esteva F. J., Shen H., Hu Y. Circulating Proteolytic Products of Carboxypeptidase N for Early Detection of Breast Cancer. Clin. Chem. 2014, 60(1): 233-242. PMID: 24146311 31. Zhao H., Li Y., Hu Y. * Nanotechnologies in Glycoproteomics. Clin. Proteomics. 2014, 11:21. 32. Fan J., Niu S., Dong A., Shi J., Wu H. J., Fine D. H., Tian Y., Zhou C., Liu X., Sun T., Anderson G. J., Ferrari M., Nie G., Hu Y. *, Zhao Y. * Nanopore Film based Enrichment and Quantification of Low Abundance Hepcidin from Human Bodily Fluids. Nanomedicine: NBM. 2014; 10(5): 879-888. Highlighted by Science Translational Medicine 33. Wu H. J., Li Y., Fan J., Deng Z., Hu Z., Liu X., Graviss E. A., Ma X., Hu Y. Antibody-Free Detection of M. tuberculosis Antigen Using Customized Nanotraps. Anal. Chem. 2014; 86 (4), pp 1988–1996. DOI: 10.1021/ac4027669 34. Shah P., Zhu X., Chen C., Hu Y., Li C. Z. * Lab-on-chip device for single cell trapping and analysis.